Data Sheet 1_Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation.pdf

Introduction<p>Sporoderm-Removed Ganoderma lucidum Spore Powder (S-GLSP), derived from the spores of the medically valued fungus Ganoderma lucidum, exhibits diverse pharmacological activities and shows considerable potential in the treatment of Alzheimer’s disease (AD). However, its underlying...

詳細記述

書誌詳細

第一著者:	Wenli Li (337819) (author)
その他の著者:	Wei Huang (36889) (author), Peng Zhou (116747) (author), Yongchuan Yao (22679309) (author), Biao Cai (4288222) (author), Shu Ye (44563) (author)
出版事項:	2025
主題:	Pharmacology sporoderm-removed ganoderma lucidum spore powder Alzheimer’s disease microglial polarization neuroinflammation NLRP3 inflammasome
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!